HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zeyu Yang Selected Research

IBS008738

2/2017TAZ Activator Is Involved in IL-10-Mediated Muscle Responses in an Animal Model of Traumatic Brain Injury.
5/2014Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zeyu Yang Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 08/2011
5Wounds and Injuries (Trauma)
01/2022 - 01/2019
4Infections
11/2022 - 01/2015
2Osteoporosis
02/2022 - 12/2021
2Hypoxia (Hypoxemia)
01/2022 - 12/2018
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
12/2021 - 01/2021
2Fibrosis (Cirrhosis)
10/2021 - 07/2021
2Urinary Bladder Neoplasms (Bladder Cancer)
08/2019 - 01/2019
1Asthma (Bronchial Asthma)
11/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Hypoparathyroidism
01/2022
1Premature Birth (Birth, Premature)
12/2021
1Triple Negative Breast Neoplasms
12/2021
1Mitochondrial Diseases (Mitochondrial Disease)
12/2021
1COVID-19
11/2021
1Communicable Diseases (Infectious Diseases)
11/2021
1Non-alcoholic Fatty Liver Disease
07/2021
1Liver Diseases (Liver Disease)
07/2021
1Disease Progression
01/2021
1Leukemia
01/2021
1Bone Resorption
01/2021
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Single Umbilical Artery
10/2020
1Congenital Abnormalities (Deformity)
10/2020
1Goiter
04/2020
1Graves Disease (Basedow Disease)
04/2020
1Tuberous Sclerosis 1
01/2020
1Multiple Myeloma
01/2020
1Carcinoma (Carcinomatosis)
01/2019

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
02/2022 - 06/2012
5HydrogelsIBA
01/2022 - 01/2019
4Biomarkers (Surrogate Marker)IBA
02/2022 - 11/2016
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018 - 01/2015
2Monoclonal AntibodiesIBA
01/2022 - 01/2021
2camrelizumabIBA
01/2022 - 01/2022
2CholesterolIBA
07/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
01/2020 - 08/2019
2IBS008738IBA
02/2017 - 05/2014
1SolutionsIBA
11/2022
1Particulate MatterIBA
11/2022
1Air Pollutants (Pollutants, Air)IBA
11/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1SugarsIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1EnzymesIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2022
1NADP (NADPH)IBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Membrane LipidsIBA
01/2022
1Nuclear Proteins (Protein, Nuclear)IBA
12/2021
1Mitochondrial DNA (mtDNA)IBA
12/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021
1VaccinesIBA
11/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
10/2021
12- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
10/2021
1Pharmaceutical PreparationsIBA
10/2021
1Coloring Agents (Dyes)IBA
10/2021
1Succinic Acid (Succinate)IBA
10/2021
1HDL LipoproteinsIBA
07/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2021
1Triglycerides (Triacylglycerol)IBA
07/2021
1OsteocalcinIBA
01/2021
1Alkaline PhosphataseIBA
01/2021
1collagen type I trimeric cross-linked peptideIBA
01/2021
1ProcollagenIBA
01/2021
1CalciumIBA
01/2021
1sodium salt monooctadecyl ester fumaric acidIBA
10/2020
1Antithyroid Agents (Antithyroid Drugs)IBA
04/2020
1Long Noncoding RNAIBA
01/2020
1MethyltransferasesIBA
08/2019
1Lysine (L-Lysine)FDA Link
08/2019
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2019
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
08/2019
1Co-Repressor ProteinsIBA
08/2019
1Histidine (L-Histidine)FDA Link
08/2019
1APOBEC-1 DeaminaseIBA
08/2019
1Proto-Oncogene Proteins c-etsIBA
08/2019
1Phosphotransferases (Kinase)IBA
08/2019
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
08/2019
1CREB-Binding ProteinIBA
08/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2019
1bis(5'-adenosyl)triphosphataseIBA
08/2019
1Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA
08/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2019
1LuciferasesIBA
04/2019
1AlginatesIBA
01/2019
1IonsIBA
01/2019
1TerbiumIBA
01/2019

Therapy/Procedure

7Therapeutics
01/2022 - 08/2015
2Thyroidectomy
01/2022 - 04/2020
2Electrodes (Electrode)
10/2021 - 01/2019
2Immunotherapy
01/2021 - 08/2019
1Injections
01/2022
1Drug Therapy (Chemotherapy)
01/2022